CAR-T Cell Therapy Breakthrough Extends Lifesaving Treatment to T-Cell Cancers FDA breakthrough status opens new frontier in precision immunotherapy The FDA has granted breakthrough therapy designation to a revolutionary CAR-T cell therapy specifically designed to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma—cancers that have long resisted the